Final Programme - iuphar

FC10 Drugs for half the world: Paediatric clinical
pharmacology
Thu 001 Sy Cushing at the child with asthma, case report
Milica Martinovic, (Republic of Serbia)
Thu 002 Using Adapt® in paediatric patients: Pharmacokinetic modelling for lamotrigine
Janet Mifsud, (Malta), D Soler, H Shabbi
Thu 003 Effects of paracetamol during first days of life
Petra Millfors, (Sweden), KJS Anand, LL Bergqvist
Thu 004 Effect of soybean on male reproductive physiology
Mehrdad Modaresi, (Iran), M Messripour, H Khorami
Thu 005 Clinical efficacy of bovine colostrum in non-organic failure to thrive
Yashar Moharamzad, (Iran), Y Panahi, G Falahi, M Falahpour
Thu 006 Blood level of Cyclosporine-A in Iranian renal transplant patients
Manijeh Motevalian, (Iran), H Otukesh, RH Shamsabadi, M Chalian
Thu 007 Safety in paediatric drug trials – an update from randomised controlled trials published in 2007
KNB Nor Aripin, Helen M Sammons, (UK), I Choonara
Thu 008 The effect of premedication for intubation on amplitude-integrated electroencephalography in a
randomized blinded intervention study of preterm infants
Elisabeth Norman, (Sweden), S Wikström, I Rosén, V Fellman, L Hellstrom-Westas
Thu 009 Pediatric outcomes following in utero exposure to psychotropic medications: An update
Irena Nulman, (Canada)
Thu 010 Pharmacokinetics, pharmacodynamics and bioequivalence of dexamethasone liquid and tablet
formulations
Christian Queckenberg, (Germany), B Wachall, P Di Gion, D Tomalik-Scharte, M Abdel-Tawab, U Fuhr
Thu 011 Population pharmacokinetics of hydrocortisone in extremely premature infants
Hesty Ramadaniati, (Indonesia), B Charles, H Liley
Thu 012 Saliva efavirenz levels as a non-invasive alternative to determine adherence in children
Malie Rheeders, (South Africa), M Viljoen, A Theron, T Meyers
Thu 013 Clinical trial of epigallocatechin-3-gallate in Duchenne muscular dystrophy
Urs T Ruegg, (Switzerland), A von Moers, F Paul, Y Nakae, O Dorchies
Thu 014 Discovery of novel pharmacological chaperones for phenylketonuria
S Santos Sierra, (Austria), A Perna, J Kirchmayer, K Kemter, DD Messing, SW Gersting, AC Muntau,
H Glossmann, G Wolber, FB Lagler
Thu 015 Oral antibodies to S100 protein in attention deficit and hyperactivity disorder: first clinical trial in
children
Svetlana Sergeeva, (Russian Federation), JL Dugina, IA Kheifets, OI Epstein
Thu 016 Prevalence of CYP2B6-516G>T polymorphism in black South African HIV-infected children on efavirenz
based antiretroviral therapy
Michelle Viljoen, (South Africa), C Dandara, M Rheeders, KR Conradie, HS Kruger, H Gous, TM Meyers
Thu 017 Population pharmacokinetics of carbamazepine and its metabolite in Chinese children with epilepsy
Li Wang, (PR China), Y Liu
280 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area